| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 35.65 | -0.10 (-0.28%) | 19.03 - 39.00 | 144.6 thousand (Below Avg) |
Market data as of 12:07PM 05/21/13. Quotes are delayed by at least 15 min.
Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by the FDA
05/14/2013 9:00 AM ET
Seattle Genetics to Present at Upcoming Investor Conferences
05/09/2013 9:00 AM ET
Seattle Genetics Reports First Quarter 2013 Financial Results
05/07/2013 4:05 PM ET